Profiel
Umut Ulge is the founder of Neoleukin Therapeutics, Inc. which was founded in 2003.
He held the title of Vice President-Translational Medicine at the company.
Dr. Ulge received a doctorate degree from the University of Washington and UW Medicine.
Eerdere bekende functies van Umut Ulge
Bedrijven | Functie | Einde |
---|---|---|
NEUROGENE INC. | Oprichter | 01-10-2021 |
Opleiding van Umut Ulge
University of Washington | Doctorate Degree |
UW Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |